Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights

Wearable technologies are increasingly used to support cardiovascular care by enabling continuous physiological monitoring beyond conventional clinical environments. Advances in consumer and medical-grade devices have expanded cardiovascular surveillance from intermittent assessments to longitudinal monitoring of heart rhythm, heart rate variability, blood pressure, heart failure status, and other physiological parameters. Concurrent advances in artificial intelligence have enhanced the ability of wearable systems to extract clinically meaningful insights from large-scale physiological data, supporting earlier disease detection, risk stratification, and personalized intervention. In this review, we examine the evolving role of wearable technologies across a 3-stage framework of cardiovascular care: surveillance, diagnosis, and intervention. We discuss established platforms, including wearable electrocardiography, photoplethysmography-based monitoring, and wearable cardioverter-defibrillators, alongside emerging modalities such as wearable ultrasound, seismocardiography, multimodal sensor fusion, and closed-loop therapeutic systems. We further highlight major technological trends, including the diversification of sensing modalities, the growing integration of artificial intelligence, and the transition from passive monitoring toward autonomous intervention. Finally, we discuss current challenges related to validation, clinical implementation, equity, privacy, and regulatory oversight. Together, these developments point toward a future in which wearable and multimodal sensing, artificial intelligence, and clinical workflows are increasingly integrated into cardiovascular disease prevention, diagnosis, and management.

Authors

Institutions

Publication Details

Journal
Arteriosclerosis Thrombosis and Vascular Biology
Published
2026-10-08
DOI
https://doi.org/10.1161/atvbaha.126.324766
Primary Topic
Non-Invasive Vital Sign Monitoring
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights

Yun‐Soung Kim, Yoon Jae Lee, Ahmed Tariq, Wonbum Sohn
Arteriosclerosis Thrombosis and Vascular Biology
Non-Invasive Vital Sign Monitoring
article

Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights

Yun‐Soung Kim, Yoon Jae Lee, Ahmed Tariq, Wonbum Sohn
article en

Abstract

Wearable technologies are increasingly used to support cardiovascular care by enabling continuous physiological monitoring beyond conventional clinical environments. Advances in consumer and medical-grade devices have expanded cardiovascular surveillance from intermittent assessments to longitudinal monitoring of heart rhythm, heart rate variability, blood pressure, heart failure status, and other physiological parameters. Concurrent advances in artificial intelligence have enhanced the ability of wearable systems to extract clinically meaningful insights from large-scale physiological data, supporting earlier disease detection, risk stratification, and personalized intervention. In this review, we examine the evolving role of wearable technologies across a 3-stage framework of cardiovascular care: surveillance, diagnosis, and intervention. We discuss established platforms, including wearable electrocardiography, photoplethysmography-based monitoring, and wearable cardioverter-defibrillators, alongside emerging modalities such as wearable ultrasound, seismocardiography, multimodal sensor fusion, and closed-loop therapeutic systems. We further highlight major technological trends, including the diversification of sensing modalities, the growing integration of artificial intelligence, and the transition from passive monitoring toward autonomous intervention. Finally, we discuss current challenges related to validation, clinical implementation, equity, privacy, and regulatory oversight. Together, these developments point toward a future in which wearable and multimodal sensing, artificial intelligence, and clinical workflows are increasingly integrated into cardiovascular disease prevention, diagnosis, and management.

Arteriosclerosis Thrombosis and Vascular Biology
Georgia State University (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 23%
Non-Invasive Vital Sign Monitoring
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.